SPEN
Basic information
Region (hg38): 1:15836095-15940456
Links
Phenotypes
GenCC
Source:
- Radio-Tartaglia syndrome (Definitive), mode of inheritance: AD
- complex neurodevelopmental disorder (No Known Disease Relationship), mode of inheritance: AD
- Radio-Tartaglia syndrome (Strong), mode of inheritance: AD
- Radio-Tartaglia syndrome (Strong), mode of inheritance: AD
- Radio-Tartaglia syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Radio-Tartaglia syndrome | AD | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Endocrine; Musculoskeletal; Neurologic | 33596411 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (403 variants)
- not_provided (364 variants)
- SPEN-related_disorder (114 variants)
- Radio-Tartaglia_syndrome (107 variants)
- not_specified (17 variants)
- See_cases (5 variants)
- Autism_spectrum_disorder (4 variants)
- Neurodevelopmental_delay (2 variants)
- Developmental_disorder (2 variants)
- SPEN-related_neurodevelopmental_disorder (1 variants)
- Breast_ductal_adenocarcinoma (1 variants)
- Myoepithelial_tumor (1 variants)
- Encephalopathy (1 variants)
- Neurodevelopmental_abnormality (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPEN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015001.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 81 | 8 | 94 | ||
| missense | 1 | 561 | 119 | 16 | 697 | |
| nonsense | 25 | 21 | 6 | 52 | ||
| start loss | 0 | |||||
| frameshift | 38 | 18 | 3 | 59 | ||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 7 | |||
| Total | 65 | 39 | 581 | 200 | 24 |
Highest pathogenic variant AF is 0.0000065733257
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SPEN | protein_coding | protein_coding | ENST00000375759 | 15 | 92597 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125730 | 0 | 18 | 125748 | 0.0000716 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.89 | 1697 | 2.07e+3 | 0.821 | 0.000124 | 23759 |
| Missense in Polyphen | 659 | 975.57 | 0.6755 | 11054 | ||
| Synonymous | -0.323 | 822 | 810 | 1.01 | 0.0000501 | 7710 |
| Loss of Function | 10.2 | 4 | 129 | 0.0310 | 0.00000872 | 1443 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000120 | 0.000120 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.000185 | 0.000185 |
| European (Non-Finnish) | 0.0000880 | 0.0000791 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2- mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}.;
- Pathway
- Notch Signaling Pathway;Notch;Notch;Notch signaling pathway;Notch-mediated HES/HEY network
(Consensus)
Recessive Scores
- pRec
- 0.160
Intolerance Scores
- loftool
- 0.206
- rvis_EVS
- -2.31
- rvis_percentile_EVS
- 1.21
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.859
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;Notch signaling pathway;viral process;negative regulation of transcription, DNA-templated;positive regulation of neurogenesis
- Cellular component
- nucleus;nucleoplasm;transcriptional repressor complex;extracellular exosome
- Molecular function
- RNA polymerase II transcription factor binding;DNA binding;transcription corepressor activity;RNA binding;protein binding